Not recommending AstraZeneca vaccine for the elderly risks the lives of the most vulnerable

The concern is not that there is data showing the vaccine to be ineffective in the elderly, it’s that there is not enough evidence to show that it is effective in this age group. The challenge is in how we manage the degree of uncertainty in the efficacy of the vaccine, given the available evidence.

Share:

Leave a Reply